Future Trends in CAR-T Cellular Immunotherapy and the Pros and Cons in Cancer Treatment
DOI:
https://doi.org/10.54097/2mssfq03Keywords:
CAR-T, Immunotherapy, Cancer Treatment.Abstract
In recent years, the basic research of tumor immunology and the research of biotechnology have made rapid progress, which provides a profound knowledge base and technical reserve for the research and development of tumor immune drugs. The move helped make the topic of tumor cell immunotherapy a household word. As of May 2019, there were a total of 1011 cell therapies in the world, of which 568 CAR⁃T therapies, accounting for 56.2%, especially CAR⁃T cells for the treatment of blood tumors, which has achieved world-renowned efficacy. However, in the treatment of solid tumors, CAR⁃T cells have not yet shown extremely accurate inhibition of solid tumors due to the presence of immunosuppressive microenvironment, most of the features (signals) of abnormal antigens are expressed in normal tissues, and other complex factors. At present, domestic and foreign research on CAR⁃T cell therapy of solid tumor has been carried out in various directions and made some progress.
Downloads
References
Peijie Shi, Jianpei Fang. (2017). Chimeric antigen receptor t-cell (car-t) therapy in the therapeutic field of common pediatric tumors. Chinese Journal of Pediatric Hematology and Oncology (1).
Chris, & Morrison. (2015). Car-t field booms as next-generation platforms attract big players. Nature biotechnology.
M.Juan, & S.Rives. (2020). [car-t immunotherapy in pediatric hemato-oncology… present and future]. Anales de pediatria, 93(1), 1-3.
Heuvel, R. V. D. (2023). Next-generation cell therapies for cancer: car-nk cells. Medicom Conference Report EBMT 2023.
Pomeroy, E. J., Lahr, W. S., Chang, J. W., Krueger, J., Wick, B. J., Slipek, N. J., et al. (2021). Non-Viral Engineering of CAR-NK and CAR-T cells using the Tc Buster Transposon System. Cold Spring Harbor Laboratory.
Xin-Yang, L., University, S. N. (2019). Advances in research of car-nk in tumor immunotherapy. Biological Chemical Engineering.
Zhang, L., Tian, L., Dai, X., Yu, H., Wang, J, & Lei, A., et al. (2020). Pluripotent stem cell-derived car-macrophage cells with antigen-dependent anti-cancer cell functions. Journal of hematology & oncology, 13(1), 153.
Pengbo Ning. (2023). A Cold and Hot Tumor-Modulated CAR-Monocyte/Macrophage Cell and Its Preparation Method and Application. CN116240173A.
Cremoni, M., Massa, F., & Sicard, A. (2022). Overcoming barriers to widespread use of car-treg therapy in organ transplant recipients. HLA, 99(6), 565-572.
Beheshti, S., Shamsasenjan, K., Ahmadi, M., & Abbasi, B. (2021). Car treg: a new approach in the treatment of autoimmune diseases. International immunopharmacology, 108409.
Williams, M. E. (2014). Further Progress in CAR-T-Cell Therapy for Acute Lymphoblastic Leukemia.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







